Reverse Design toward Optimized Labeled Chemical Probes - Examples from the Endocannabinoid System.

Area of Science:

• Medicinal Chemistry
• Chemical Biology
• Pharmacology

Background:

• Labeled chemical probes are crucial for drug discovery, aiding target validation, assay development, and clinical trials.
• Probes require high potency, selectivity, and favorable ADMET profiles for successful translation.
• Advancements in imaging and proteomics necessitate specialized probes for drug discovery applications.

Purpose of the Study:

• To explore the reverse-design approach for generating high-quality labeled chemical probes.
• To demonstrate the application of reverse design for probes targeting the endocannabinoid system (ECS).
• To highlight the utility of diverse reporter groups for various probe applications.

Main Methods:

• Utilizing small molecules from medicinal chemistry programs as a basis for probe generation.
• Applying the reverse-design strategy to create labeled probes.
• Incorporating diverse reporter units for specific applications.

Main Results:

• The reverse-design concept was successfully applied to generate labeled probes targeting the endocannabinoid system (ECS).
• The study showcases probes with diverse reporter units suitable for a range of applications.
• Collaborative efforts between academic and industry research programs were instrumental in probe development.

Conclusions:

• The reverse-design approach offers a viable strategy for creating high-quality, application-specific chemical probes.
• Labeled probes targeting the ECS were successfully generated using this methodology.
• Cross-sector collaborations can serve as a model for future probe generation initiatives.